Detalles de la búsqueda
1.
Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial.
Ann Rheum Dis
; 82(11): 1394-1403, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37607809
2.
Carbon-Footprint Analyses in RCTs - Toward Sustainable Clinical Practice.
N Engl J Med
; 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38749030
3.
Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study.
Ann Rheum Dis
; 81(3): 398-401, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34625404
4.
Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment.
Ann Rheum Dis
; 81(3): 344-350, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34389605
5.
All-cause and cause-specific mortality in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: a nationwide registry study.
Rheumatology (Oxford)
; 61(12): 4656-4666, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35377442
6.
Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial.
JAMA
; 325(17): 1755-1764, 2021 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33944875
7.
Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study.
Rheumatology (Oxford)
; 59(3): 505-512, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31504942
8.
Conventional versus ultrasound treat to target: no difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritis.
Rheumatology (Oxford)
; 59(9): 2550-2555, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31999341
9.
Subclinical inflammation and joint damage progression in patients with early RA fulfilling 2011 vs 2022 ACR/EULAR Boolean remission criteria: data from the ARCTIC study.
Ann Rheum Dis
; 83(4): 540-541, 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38049997
10.
Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes.
Ann Rheum Dis
; 77(10): 1421-1425, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29934373
11.
Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol.
Rheumatology (Oxford)
; 57(11): 2022-2031, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30053199
12.
Discontinuation of Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Excellent Disease Control.
JAMA
; 329(12): 1024-1026, 2023 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36976288
13.
[Service user involvement can improve research]. / Brukermedvirkning kan gi bedre forskning.
Tidsskr Nor Laegeforen
; 143(9)2023 06 13.
Artículo
en Nor
| MEDLINE | ID: mdl-37341398
14.
Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria.
Ann Rheum Dis
; 76(2): 341-345, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27094444
15.
Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis.
Ann Rheum Dis
; 76(12): 2031-2037, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28814431
16.
Joint tenderness and ultrasound inflammation in DMARD-naïve patients with early rheumatoid arthritis.
Ann Rheum Dis
; 80(11): 1493-1494, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34083205
17.
Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs and Disease Flare in Patients With Rheumatoid Arthritis-Reply.
JAMA
; 326(9): 873, 2021 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34547085
18.
Use of direct-acting anticoagulants (DOACs) delays surgery and is associated with increased mortality in hip fracture patients.
Eur J Trauma Emerg Surg
; 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38713220
19.
Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activity.
RMD Open
; 10(1)2024 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38216290
20.
Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial.
Lancet Rheumatol
; 6(5): e268-e278, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38583450